Home Technology With No Buyers In Sight, Rackspace Dives

With No Buyers In Sight, Rackspace Dives

When you purchase through our sponsored links, we may earn a commission. By using this website you agree to our T&Cs.

Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL), dELiA*s, Inc. (NASDAQ:DLIA) and Voltari Corp (NASDAQ:VLTC) are made major gains on the stock market this Wednesday. Posting big losses are Rackspace Hosting, Inc. (NYSE:RAX), NII Holdings Inc (NASDAQ:NIHD) and Repros Therapeutics Inc (NASDAQ:RPRX).

Sign Up For Our Free Newsletter

Auxilium Climbs on Endo Acquisition Bid

The share price of Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) jumped +44.89% this Wednesday, ending the day at $31.18 – rather close to its 52-week high of $32.89. The surge comes on the heels of a $2.2 billion acquisition bid made by Endo International. The company is also in the midst of a merger with QLT. The John Paulson pick is up +50.41% YTD.


dELiA*s, Inc. (NASDAQ:DLIA) climbed +29.45% today, rebounding from what has been a tough couple of days on Wall Street. In the Tiger Global portfolio since the fourth quarter of 2013, dELiA*s is down -68.17% year-to-date.

Voltari Corp (NASDAQ:VLTC) had a strong day as well, as its price surged +12.65%. Activist investor Carl Icahn initiated a position in the mobile data solutions provider during the second quarter of 2013, and by the looks of it, he’s still waiting for his investment to pay off. Despite today’s gain, Voltari has declined -64.65% over the past year.

Rackspace Plunges

Rackspace Hosting, Inc. (NYSE:RAX) ended the day with a -17.67% loss following the announcement that it has ended its sale exploration without securing a buyer or partner. Billionaires Dan Loeb and George Soros initiated stakes in the company during the second quarter of this year, as did Ray Dalio in Q1. In spite of today’s decline, RAX has climbed +3.78% in the last month.

NII Holdings Inc (NASDAQ:NIHD) dipped -12.35% and continues to suffer the fall-out of its bankruptcy protection filing, made this week. The new Q2 Soros pick has declined -40% in five days.

Taking the third and final spot on today’s list of losers is Repros Therapeutics Inc (NASDAQ:RPRX), the share price of which fell -10.49%. In the Farallon Capital portfolio since Q2 2013, RPRX is down -29.62% YTD.

Sign Up For Our Free Newsletter


Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.


Want Financial Guidance Sent Straight to You?

  • Pop your email in the box, and you'll receive bi-weekly emails from ValueWalk.
  • We never send spam — only the latest financial news and guides to help you take charge of your financial future.